Assessing an EEG Biomarker of Response to TMS for Major Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

266 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-19

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Veterans with treatment resistant depression (TRD) have the opportunity to receive transcranial magnetic stimulation (TMS) treatment via the VA's National TMS Clinical Pilot Program. While some see improvement with their depression, others do not. Therefore, it may be beneficial to be able to predict with biomarkers what participants may see improvement with their treatment. Electroencephalography (EEG) is a means to identify such biomarkers. Four hundred Veterans with TRD will be enrolled in this trial to determine whether neuroimaging biomarkers of repetitive transcranial magnetic stimulation (TMS) can be prospectively replicated in a large ecologically valid sample. Participants will have a total of EEG scans at baseline, every 5th treatment session, and at the end of treatment for a total of 7 EEG scans.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neural Circuit Biomarkers of Transcranial Magnetic Stimulation Study

NCT04663841

Depression

ACTIVE_NOT_RECRUITING

Brain-Based Biomarkers in Response to TMS in MDD

NCT02843373

Major Depressive Disorder Depression

COMPLETED

Individualized (fMRI-guided) TMS Treatment for Depression

NCT06266390

Depression Major Depressive Disorder Persistent Depressive Disorder

RECRUITING NA

Sensory Synchronized Imaging and Neuromodulation

NCT06548113

Major Depressive Disorder

RECRUITING NA

TMS With Real-time E-field and EEG Source Imaging

NCT06645613

Healthy Volunteers Only

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goals of this study are to: (1) test a potential predictive resting EEG biomarker of antidepressant response (differential patters of gamma oscillations) in a large sample of Veterans with TRD receiving TMS (N=400); (2) assess whether a second putative biomarker (early changes in theta cordance during treatment) predict eventual response to TMS, as well as, leverage this large sample to identify other potential biomarkers (such as markers of early versus late response to TMS, markers of response to other TMS parameters (e.g., 5 Hz, 1 Hz or theta burst TMS), and markers of change with treatment that may speak to mechanism); and (3) create an infrastructure to rapidly identify and test additional EEG-based biomarkers of treatment response in patients with depression and other psychiatric conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation is delivered as part of routine care and is not managed by this observational study.

Transcranial Magnetic Stimulation

Intervention Type OTHER

Transcranial Magnetic Stimulation is delivered as part of routine care and is not managed by this observational study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation is delivered as part of routine care and is not managed by this observational study.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TMS; Repetitive Transcranial Magnetic Stimulation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Veterans participating in the VA TMS Pilot Program age 18 years or older
* Able to provide written informed consent to participate in the EEG portion of this study and to allow linking such data to data collected as part of the TMS Pilot Program
* Diagnosis of MDD based on DSM-5 criteria and be currently depressed despite prior treatment with at least one adequate antidepressant treatment
* Receiving stable doses of psychiatric medications (no dose changes for \>4 weeks prior to study entry), in stable psychotherapy, or receiving no psychiatric medications and/or psychotherapy

Exclusion Criteria

* History of seizure disorder
* Known structural or neurologic abnormalities present or close to the treatment site that would increase risk of seizure
* History of brain surgery
* History of recent traumatic brain injury (within 6 months) or any history of moderate to severe traumatic brain injury
* Clinical evidence of severe or uncontrolled alcohol or substance use disorders within three months
* Active withdrawal from alcohol or other substances of abuse
* Implanted metal device in the head that would increase the risk of TMS
* Metal in the head that would increase the risk of TMS
* Current psychosis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No